Luis Cardenas, DO
Surgical Critical Care · Newark, DENPI 1093033482
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $237 and has fallen 68.3% since, to $75 in 2025.
Across 20 payments — averaging $37.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$130
- Edwards Lifesciences$114
- AstraZeneca$113
- Biotissue Holdings Inc.$65
- Davol Inc.$63
- Smith+Nephew$63
- plus $191 from 7 others
Across 3 payments — averaging $2166.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Chiesi USA, Inc.$7K
What the payments were for
- Food & beverage$740100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanos Medical | 1 | $130 |
| Edwards Lifesciences | 3 | $114 |
| AstraZeneca | 2 | $113 |
| Biotissue Holdings Inc. | 2 | $65 |
| Davol Inc. | 1 | $63 |
| Smith+Nephew | 2 | $63 |
| Solventum Corporation | 2 | $59 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Teleflex LLC | 1 | $37 |
| Convatec Inc. | 1 | $17 |
| BD | 1 | $15 |
| Shire North American Group Inc | 1 | $12 |
| CSL Behring | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few surgical critical care providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Chloride0.9 % Sodium Chloride | 150 | $7,704 |
| Lactated RingersRinger's Solution,lactated | 119 | $3,802 |
| Sodium ChlorideSodium Chloride 0.45 % | 53 | $2,262 |
| Potassium PhosphatePotassium Phos,m-Basic-D-Basic | 14 | $1,940 |
| Potassium Chloride | 52 | $1,871 |
| Octreotide Acetate | 13 | $600 |
| Magnesium Sulfate | 45 | $491 |
| Famotidine | 23 | $256 |
| Ondansetron HclOndansetron Hcl/Pf | 16 | $71 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Newark
- Jonathan ImranNewark$8K
- Raymond GreenNewark$1K
- Gerard FuldaNewark$848
- Michael KollarNewark$760
- Adina McNairNewark$581
- Jeffry ZernNewark$557
- Sandra MedinillaNewark$293
- Jorge Liporaci LucenaNewark$167
- Marcin JankowskiNewark$101
- Frederick GibersonNewark$52
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.